Peer Review History
| Original SubmissionOctober 31, 2024 |
|---|
|
PONE-D-24-49625Zebrafish Polymerase Theta and human Polymerase Theta: orthologues with homologous function.PLOS ONE Dear Dr. Weicksel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please submit your revised manuscript by Jan 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “SEW - P20GM103430 - Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence. - https://web.uri.edu/riinbre/ - RI-INBRE was not part of the study JBTW - R15GM144903-01 - National Institute of General Medical Sciences of the National Institutes of Health - NIGMS was not part of the study” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. Additional Editor Comments: Manuscript is reviewed by 2 subject experts and their comments are appended below for your attention. I have gone through it and concur their comments. Additionally, authors are advised to check the processivity of both the polymerases. Results may help to distinguish if length of polymerization shown in Fig 4, is because of higher processivity of the enzyme or the ability of enzyme to reinitiate in multiple events. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this study by Thomas et al, demonstrated that the polymerase domain of polymerase theta (POLQ) from zebrafish and human has a similar function in terms of amplifying damaged DNA strands. The authors employed several conventional biochemical and biophysical approaches to examine the several functional aspects of human POLQ in zebrafish POLQ. Finally, they conclude stating that both human and zebrafish polymerase domains are functional orthologs. While this is a fundamental investigation and enriches our understanding about the POLQ functionality in a popular biological model organism zebrafish, there are several demerits in the technical design of the study, interpretation of results and providing strong supportive evidence to establish their statement. Hence, the manuscript in its present form does not meet the scientific rigor and publication standard of the concerned journal. The authors may consider the following points to further strengthen the manuscript. Major concerns: 1) It is not clearly mentioned whether full-length zPOLQ was tested and compared to that hPOLQ. 2) In terms of fold-change, how efficient is the zPOLQ compared to hPOLQ? 3) Regarding the lesion bypass capacity of POLQ, the authors only showed thymidine dimer adduct. Can zPOLQ bypass any bulky adduct, oxidative base damage, or nicked strand lesion in the dsDNA region to extend the single-stranded region? 4) What was the basis of choosing different duplex and SS oligo sequences? Are they preferred binding sequences or any random ones? 5) Regarding the participation of zPOLQ in MMEJ, what was the microhomology sequence length using in the in vitro analysis? 6) An in vitro MMEJ reporter-based assay would be ideal to show zPOLQ's possible functional role in MMEJ pathway. 7) None of the experiments had statistical analysis and no mentioning of the number of biological replicates. 8) Without any in-cell assays, it is difficult to ascertain the functional similarities of these two POLQ domains. Minor concern: 1) Lacking citations of many of the pioneering reports in the field. 2) The manuscript requires improvement in English writing style. 3) Most images are of poor quality. 4) Figure 1 requires domain marking for easy readout by readers. 5) Figure 2A should indicate the band size and exact domain name of the purified protein. Mention purity level of each of human and zebrafish POLQ domains. Total yield is ambiguous as there are other non-specific bands visible in the gel image. 6) Figure 3A, mention the DNA type used in this assay, preferably in the Y-axis. 7)Figure 6 requires statistical qunatification of the activity. Reviewer #2: The topic of the manuscript entitled “Zebrafish Polymerase Theta and human Polymerase Theta: orthologues with homologous function” is a detailed and extensive characterization of the Danio rerio (zebrafish) DNA polymerase theta (θ). It is primary research that fills a large gap in our scientific knowledge about an important enzyme of a major model organism. First, the authors show sequence and structural similarity bioinformatically between the human and zebrafish Pol θ (hPol θ and zPol θ, respectively). Then, they overexpress and purify the polymerase domain of both proteins for biochemical characterization. They use a large number of in vitro methods to study and to compare the DNA binding, primer extension, microhomology-mediated end joining and translesion synthesis activities of the two orthologous proteins. They also examine the effect of various divalent cations on the polymerization activity of these Pol θs. The study is well-designed and thorough. Experiments are performed to a high technical standard and are described in sufficient detail. Conclusions are supported by the data. Nevertheless, there are shortcomings in the data presentation that need improvement. Major Points: 1. Abstract - The authors emphasize the role of loop regions in key functions of Pol θ. However, they do not have any experimental evidence for the role the loop regions of zPol θ play (They have not performed any assays using Pol θ mutants with deleted or point-mutated loops). Therefore, the abstract should be reworded to reflect the true content of the study, and summarize the findings . 2. Fig 1. Structural modeling of zPol θ. - Is this the full length zPol θ or just the polymerase and exonuclease domains? Amino acid numbers should be included in the legend. In Supplemental figure 1 amino acids 1-799 and 1-744 of hPolQ and zPolQ are aligned. However, in Materials and Methods, line 389 says that “polymerase domain of zebrafish Pol θ (residues 1801-2579)” and also elsewhere in the text they refer to “c-terminal zPol θ” (lines 122 and 200). Perhaps a scheme of the domain structure of zebrafish Pol θ showing amino acid numbers should be included in Figure 1. Similarly, in Table 1 exact residues ‘from - to’ should be given. 3. Fig 3. zPol θ binds tightly to ds DNA – Line 151 says that “products were separated on a 6% non-denaturing gel”, however, line 146 contradicts saying “products were separated on a denaturing gel” (probably incorrect, since line 490 states “Native PAGE”). Furthermore, Fig. 3 shows only the quantitation, not the gel. Since the authors declare in Data Availability that “All relevant data are within the manuscript and its Supporting Information files”, gels should be shown too, either in the main Figure 3, or in the Supplementary file. Moreover, since the experiment should be performed three times, error bars should be included in the graph. 4. Fig 4. zPol θ experiences greater nucleotide extension activity compared to hPol θ. - Line 182 states that “Under steady-state conditions 50 nM hPol θ or zPol θ were preincubated with 200 nM 25/40 dsDNA, however line 159 says (probably incorrectly) that “Under standard steady-state conditions, 200 nM of zPol θ or hPol θ was preincubated with 50 nM 25/40 dsDNA”. 5. Fig 5. zPol θ experiences biphasic burst activity. - Again, like for Fig. 3, it would be nice to see the gels that were quantitated here. 6. Fig. 6 zPol θ is able to perform MMEJ activity - This figure is not perspicuous. Firstly, probably a C is missing from the lower strand, and this way it looks as if there is a G:G mispairing with the upper strand. Secondly, it is not clear how many nucleotides Pol θ adds to the ssDNA. Explanations showing ’n’ and ’n+x’ are missing (In the raw gels file there is a caption “double-stranded DNA”). Interestingly, it looks as if a lot of nucleotides are added, at least 10, even though the templating part in the structure is only 6 nt long. Or is the run different just because this is a native gel, not a denaturing one? The authors could pre-anneal the ssDNA for control. Alternatively, the extended product can be run on a denaturing gel to see the exact size or shorter reaction times could be used to see shorter extended products. Line 229-230 in the main text says “We hypothesize the smaller product bands are indicative of classic snap-back synthesis”. This is not clear either, the authors could mark in the figure which “smaller product bands” they mean. 7. Fig. 7 - Unfortunately, Fig. 7 is missing from the manuscript uploaded to PLOS One site. There is another copy of Fig. 4 here. The intended Fig 7 can be judged from the Supplementary raw gels file. The left part of the gel image (with Mg2+) shows some running anomalies and smears. It is not clear if dCTP is incorporated at all, and whether one or two dGTPs are incorporated opposite the T-T dimer. Moreover, it cannot be established after which nucleotide Pol θs stall in case dATP is added. Since probably all experiments have been repeated 3 times, the authors should provide another gel picture with clearer bands. 8. Fig. 8. - Unfortunately, Fig. 8 is also missing from the manuscript! The intended Fig. 8 can be assessed from the Supplementary raw gels file. There are smears/ running anomalies here again. Line 276 says “hPol θ could incorporate every nucleotide to some extent”, however, it seems as if there was no incorporation of dCTP and dTTP. The authors may want to provide another gel picture with clearer bands. 9. Materials and Methods Template oligonucleotides are given in 3’ to 5’ direction in lines 464, 467 and 470. This contradicts conventions and the format to show dsDNA will not work in text. Annealed ds substrates could be shown in a table, or may not be necessary, if they are shown in the figures (like Fig. 4). 10. Line 494, mx, x, Y, and b should be specified, explained. Similarly, kobs and kss should be specified in line 508. 11. The Discussion needs improvement in writing. E. g. line 314 can be deleted. The authors could discuss whether polymerases of D. rerio have been biochemically or genetically characterized yet. Minor Points: 1. The manuscript should undergo extensive language and grammar corrections. For example, “zPol θ experiences greater nucleotide extension activity” should read ‘zPol θ exerts/ exercises/ has/ possesses higher nucleotide extension activity’. “zPol θ catalytic activity similar to other DNA polymerases” should read ‘zPol θ catalytic activity is similar to other DNA polymerases’. e.t.c. 2. The References/ Work Cited does not follow a uniform format. The publication date is given as year (e.g. line 610) or year, month (e.g. line 603), or year, month, day (e.g. line 606) or the publication date is missing (line 613). 3. Supplement 2. “hWT and zWT Pol θ” name is used. Are these proteins the same as the ones in the other figures? If so, they should be called ‘hPol θ and zPol θ’, just like in the other figures. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Joy Mitra Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-49625R1Zebrafish Polymerase Theta and human Polymerase Theta: orthologues with homologous function.PLOS ONE Dear Dr. Weicksel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Tiff file of Figure 3 seems missing. When we click button for Figure 3, it downloads figure 4 and so on... Please correct it, recheck it carefully before resubmitting. Please submit your revised manuscript by Mar 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Zebrafish Polymerase Theta and human Polymerase Theta: orthologues with homologous function. PONE-D-24-49625R2 Dear Dr. Weicksel, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-49625R2 PLOS ONE Dear Dr. Weicksel, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Hari S. Misra Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .